Tatva Chintan Pharma Chem (NSE:TATVA) Tariff Resilience Score: 0/10 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
82 GF Score
Price ₹1,788.20
GF Value ₹1,502.93
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Tariff Resilience Score?

Tatva Chintan Pharma Chem has the Tariff Resilience Score of 0, which implies that the company might have .

Tatva Chintan Pharma Chem has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Tatva Chintan Pharma Chem might have .

Tatva Chintan Pharma Chem  (NSE:TATVA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Tatva Chintan Pharma Chem Tariff Resilience Score Related Terms

NSE:TATVA
82GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued. The current stock price of ₹1,788.20 is trading 19% above its estimated GF Value™ of ₹1,502.93. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.

Key valuation signals for NSE:TATVA:

  • Tariff Resilience Score: 0
  • GF Value™: ₹1,502.93 vs. price of ₹1,788.20 (19% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score

Get the complete analysis for NSE:TATVA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,788.20
Price
₹1,502.93
GF Value